Pocket Option
App for

Pocket Option Long Châu Stock Code

31 July 2025
10 min to read
Long Châu Stock Code: Comprehensive Analysis and Potential Investment Opportunities

The Long Châu stock code has been attracting special attention from Vietnamese investors recently. This article will provide an in-depth analysis of the prospects, risks, and investment opportunities in this stock, along with smart strategies to help investors make informed decisions in the current market context.

Overview of Long Chau stock code and position in the Vietnamese pharmaceutical market

Long Chau is one of the largest pharmacy chains in Vietnam, owned by FPT Retail Joint Stock Company (ticker: FRT). Tracking and analyzing Long Chau stock is essentially evaluating the FRT stock code and the impact of this pharmacy chain on the parent company’s stock value. Since being acquired by FPT Retail in 2017, Long Chau has grown dramatically from 4 stores to over 1000 stores nationwide by 2024.

In the context of Vietnam’s pharmaceutical industry growing at a rate of about 10-15% annually, Long Chau has quickly captured a significant market share. Compared to competitors like Pharmacity and An Khang Pharmacy, Long Chau stands out with its rapid expansion strategy combined with an efficient business model. This is why many investors are interested in Long Chau stock as a potential investment opportunity.

Year Number of stores Revenue (billion VND) Proportion of FRT revenue
2019 30+ ~500 5%
2020 160+ ~1,100 8%
2021 350+ ~4,300 23%
2022 650+ ~8,800 38%
2023 950+ ~16,500 55%
2024 (estimated) 1200+ ~25,000 65%

Financial expert Nguyen Minh Hoang from Pocket Option notes: “”Long Chau has become the main growth driver for FPT Retail, with an increasingly significant contribution to the parent company’s revenue and profit. This makes Long Chau stock – or more precisely, FRT – attractive to many long-term investors.””

Analysis of fundamental factors affecting Long Chau stock

Financial situation and operational efficiency

To properly assess the potential of Long Chau stock, investors need to understand the financial situation and operational efficiency of this pharmacy chain within the structure of FPT Retail. Since being acquired by FRT, Long Chau has demonstrated exceptional growth with rapid expansion and high business efficiency.

Financial indicator 2022 2023 2024 (Q2) Assessment
Long Chau’s gross profit margin 22.5% 23.8% 24.2% Positive
Long Chau’s EBITDA (billion VND) 450 780 480 (half year) Positive
Revenue growth rate 105% 88% 52% High but slowing down
Average revenue/store (billion VND/year) 14.5 17.2 18.4 (estimated) Positive
Average new store opening cost (billion VND/store) 1.2 1.3 1.35 Stable

Long Chau’s development has created strong growth momentum for the FRT stock. From 2020 to 2023, the stock value increased by more than 300%, largely due to the success of the Long Chau pharmacy chain. However, in 2024, the stock price has corrected by about 25-30% from its peak, due to concerns about potentially slowing growth and increasing competitive pressure.

Development strategy and competitive position

Long Chau has built its competitive advantage based on three main pillars: rapid expansion, efficient supply chain management, and superior customer experience. Compared to its main competitor, Pharmacity (which is facing financial difficulties), and the An Khang chain (owned by The Gioi Di Dong), Long Chau has implemented a more effective “”controlled growth”” strategy.

Competitive factor Long Chau Pharmacity An Khang
Number of stores (2024) ~1200 ~800 (reduced from peak) ~500
Pricing strategy Competitive, many promotional programs Medium-high Medium
Strengths Wide network, professional pharmacists Modern experience Integration with MWG ecosystem
Financial situation Strong, backed by FPT Difficult, restructuring Stable, backed by MWG

One of the important factors affecting Long Chau stock is the chain’s expansion strategy in the coming years. FPT Retail’s leadership has set a target of 2,000 stores by 2026, focusing on suburban and rural areas where there is still significant development potential.

Technical analysis and price trends of Long Chau stock

In this section, we will analyze the price chart and technical indicators of the FRT stock – representing Long Chau stock on the Vietnamese stock market. This is an important tool to help investors determine appropriate times to buy or sell.

Looking at the long-term trend, from 2020 to mid-2023, Long Chau stock had a strong upward cycle, from 15,000-20,000 VND to a peak of about 90,000-95,000 VND. However, from late 2023 to early 2024, the stock has undergone a correction period, currently trading in the 65,000-70,000 VND range.

  • The MA50 and MA200 lines are showing signs of divergence, with the MA50 cutting below the MA200 in February 2024, signaling a downward trend in the short and medium term.
  • The RSI indicator is in the 40-45 range, showing that the stock is not oversold but also lacks strong upward momentum.
  • Average trading volume decreased by 25-30% compared to the 2022-2023 period, reflecting investor caution.
  • Strong support zone is at 60,000-62,000 VND, while important resistance is at 75,000-78,000 VND.

According to analysis from Pocket Option experts, in the short term, Long Chau stock may continue to fluctuate within the range of 60,000-75,000 VND, waiting for new information on business results and development strategy.

Important price levels Value (VND) Significance
Strong support 1 60,000-62,000 Historical accumulation zone, high volume
Strong support 2 55,000-57,000 61.8% Fibonacci retracement of 2020-2023 rally
Resistance 1 75,000-78,000 Recent short-term peak, strong selling zone
Resistance 2 85,000-90,000 Historical peak zone, difficult to break in short term

Impact of macroeconomic factors on Long Chau stock

In addition to company-specific factors, Long Chau stock is also strongly influenced by Vietnam’s macroeconomic environment and policies. Here are the main factors that are and will impact the stock’s prospects in the coming period:

  • Economic growth: Vietnam’s GDP is forecast to grow by about 6-6.5% in 2024, creating a positive foundation for the pharmaceutical retail industry to develop.
  • Inflation: An inflation rate of about 3.5-4% may put pressure on operating costs but also allows Long Chau to adjust selling prices.
  • Monetary policy: Low interest rates create conditions for FRT to raise capital at low costs to expand the Long Chau chain.
  • Aging population trend and increased health awareness: These are long-term drivers for the development of Vietnam’s pharmaceutical market.

Particular attention should be paid to changes in Vietnam’s health and pharmaceutical policies. New regulations on pharmaceutical business, health insurance, and prescription drugs can create both challenges and opportunities for the Long Chau chain. Investors interested in Long Chau stock need to closely monitor these developments.

Macroeconomic factor Negative impact Positive impact Level of influence
Drug price control policies May reduce profit margins Creates a level playing field, beneficial for large chains High
Health insurance payments Requires system investment Increases customer flow to pharmacies Medium
Prescription drug regulations Reduces sales of certain products Increases the advisory role of pharmacists High
Consumption trends during recession Reduced spending on non-essential medications Medication is essential, less affected Low

Investment strategy for Long Chau stock: Expert advice

Based on comprehensive fundamental and technical analysis, here are appropriate investment strategies for Long Chau stock in the current context:

Investment strategy by time horizon

For short-term investors (under 6 months), I from Pocket Option recommend:

  • Wait for correction phases to the support zone of 60,000-62,000 VND to consider buying.
  • Apply a “”buy low, sell high”” strategy within the trading range of 60,000-75,000 VND.
  • Use technical indicators such as RSI, MACD, and Bollinger Bands to identify entry and exit points.
  • Set a stop-loss threshold of about 5-7% below the purchase price and a profit target of 10-15%.

For medium and long-term investors (1-3 years or more), the strategy may be different:

  • Accumulate shares during strong market corrections.
  • Focus more on fundamental analysis and Long Chau’s development prospects rather than short-term price fluctuations.
  • Establish an investment plan using the Dollar Cost Averaging (DCA) method to minimize volatility risk.
  • Closely monitor quarterly financial reports and Long Chau’s expansion plans to adjust strategy in a timely manner.
Type of investor Recommended strategy Time to act Profit target
Short-term (3-6 months) Trade according to technical trends Buy at 60,000-62,000 zone, sell at 70,000-75,000 10-15%
Medium-term (6-18 months) Buy and hold with adjustments Accumulate during market corrections 20-30%
Long-term (1-3 years) Invest based on fundamentals Gradually allocate capital, less concerned with timing 40-60%
Ultra-long-term (3+ years) Invest in Vietnam’s pharmaceutical industry growth Buy and hold, reinvest dividends 100%+

Experts from Pocket Option emphasize: “”Regardless of which strategy you choose, investors need to understand that Long Chau stock will continue to experience strong fluctuations in the coming period. Fierce competition in the pharmaceutical retail industry, along with changes in regulations and policies, will create both challenges and opportunities. Therefore, risk management and portfolio diversification remain core principles.””

Potential risks and prevention methods when investing in Long Chau stock

Despite many positive factors, Long Chau stock still has notable risks that investors need to be aware of and have appropriate prevention strategies:

  • Competitive risk: Vietnam’s pharmaceutical retail market is witnessing fierce competition, with the participation of large chains and many independent pharmacies. In particular, Pharmacity’s recovery after restructuring or The Gioi Di Dong’s strong investment in the An Khang chain could put pressure on Long Chau’s market share.
  • Legal risk: Changes in regulations regarding pharmaceutical business, prescription drugs, or drug prices can significantly affect Long Chau’s business model and profit margins.
  • Risk of overly rapid expansion: The high rate of new store openings may lead to issues with quality management, personnel, and cost control, thereby affecting overall business efficiency.
  • Valuation risk: With a current P/E of about 22-25 times, Long Chau stock is valued at a high level compared to the retail industry average. Any slowdown in growth could lead to a strong price correction.

To prevent these risks, investors can apply the following measures:

Type of risk Preventive measure Supporting tools
Market risk Diversify investment portfolio Allocate capital across different industry groups
Price volatility risk Use stop-loss orders Set stop-loss orders at 7-10% below purchase price
Liquidity risk Don’t invest too heavily in one stock Limit FRT proportion to 5-10% of portfolio
Information risk Closely follow reports and news Subscribe to notifications from securities companies

Pocket Option provides many analytical and risk management tools that can help investors effectively monitor and manage investments in Long Chau stock, including price alert systems, technical analysis tools, and a simulation trading platform to test strategies.

Conclusion and long-term outlook for Long Chau stock

After a comprehensive analysis of the factors affecting Long Chau stock, we can draw some conclusions and forecasts about the long-term prospects of this stock:

Fundamentally, Long Chau is in a favorable position in Vietnam’s pharmaceutical retail industry with a widespread network, strong brand, and financial backing from FPT Retail. The main growth drivers come from store expansion, improving revenue per store, and optimizing the cost structure.

In the medium and long term (3-5 years), Vietnam’s pharmaceutical market is expected to continue strong growth thanks to the increase of the middle class, aging population, and increasing healthcare needs. In this context, Long Chau has the opportunity to consolidate its leading position and expand market share.

However, investors should note that Long Chau stock also faces significant challenges, including intense competition, profit margin pressure, and risks from regulatory changes. This could lead to strong price volatility in the short term.

Looking at the long term, with a clear development strategy and a solid position in the pharmaceutical retail industry, Long Chau stock remains a potential investment choice for patient investors who can withstand short-term volatility.

Pocket Option recommends that investors apply a time-based capital allocation strategy, accumulate shares during strong market corrections, and regularly reassess prospects based on the latest financial reports and market developments.

With a vision to 2030, Long Chau stock has the potential to become one of Vietnam’s blue-chip stocks in the retail sector, reflecting the sustainable development of the pharmaceutical and health industry in a rapidly developing economy.

FAQ

What stock code does Long Chau trade under on the Vietnamese stock market?

Long Chau stock is not directly traded on the Vietnamese stock market. Long Chau is a pharmacy chain owned by FPT Retail Joint Stock Company, so when investing in Long Chau, investors need to buy FRT stock (FPT Retail's stock code) on the HOSE exchange.

What are the main factors affecting the value of Long Chau stock in 2024-2025?

The main factors affecting the value of Long Chau stock (FRT) in 2024-2025 include: the speed of store network expansion, operational efficiency (revenue and profit per store), competition in the pharmaceutical retail industry, changes in pharmaceutical business regulations, and Vietnam's macroeconomic situation. In particular, Long Chau's ability to maintain revenue growth and improve profit margins will be decisive factors.

How to evaluate the best time to buy Long Chau stock?

The best time to buy Long Chau stock (FRT) is typically when: (1) The stock adjusts to a strong technical support area (currently around 60,000-62,000 VND); (2) The company announces positive business results or ambitious expansion plans; (3) The general market has a strong correction causing the stock to be oversold; (4) Technical indicators such as RSI show the stock is in the oversold zone. Investors should combine fundamental and technical analysis to determine the appropriate buying time.

What tools does Pocket Option provide to support investment in Long Chau stock?

Pocket Option provides many tools to support investment in Long Chau stock, including: a technical analysis platform with numerous indicators and charting tools, automated price alert systems, regular fundamental and technical analysis reports, a simulated trading platform to test investment strategies without risk, and personalized investment advisory services. In particular, Pocket Option also provides risk management tools to help set automatic stop-loss and take-profit levels.

What are the biggest risks when investing in Long Chau stock and how to minimize these risks?

The biggest risks when investing in Long Chau stock include: competition risk from other pharmacy chains, legal risks from changes in pharmaceutical business regulations, risks from too rapid expansion affecting management efficiency, and high valuation risk leading to strong corrections if business results don't meet expectations. To minimize these risks, investors should: diversify their investment portfolio, use stop-loss orders to limit losses, allocate investment capital over time rather than investing at once, and regularly update information about the company and industry to adjust strategies in a timely manner.

User avatar
Your comment
Comments are pre-moderated to ensure they comply with our blog guidelines.